Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.4.3.13 (
lysyl oxidase
)
1,248
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Intra- and intermolecular covalent cross-linking between collagen fibrils, catalyzed by
lysyl oxidase
(
LOX
), determines the mechanical properties of connective tissues; however, mechanisms that regulate the collagen cross-linking according to tissue specificity are not well understood. Here we show that periostin, a secretory protein in the dense connective tissues, promotes the activation of
LOX
. Previous studies showed that periostin null mice exhibit reduced collagen cross-linking in their femurs,
periosteum
, infarcted myocardium, and tendons. Presently, we showed that active
LOX
protein, formed by cleavage of its propeptide by bone morphogenetic protein-1 (BMP-1), was decreased in calvarial osteoblast cells derived from periostin null mice. Overexpression of periostin promoted the proteolytic cleavage of the propeptide, which increased the amount of active
LOX
protein. The results of co-immunoprecipitation and solid phase binding assays revealed that periostin interacted with BMP-1. Furthermore, this interaction probably resulted in enhanced deposition of BMP-1 on the extracellular matrix, suggesting that this enhanced deposition would lead to cleavage of the propeptide of
LOX
. Thus, we demonstrated that periostin supported BMP-1-mediated proteolytic activation of
LOX
on the extracellular matrix, which promoted collagen cross-linking.
...
PMID:Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. 2018 49